PFIZER, MODERNA: and... action!
This is what happened this week. Pfizer announced that basically its vaccine works well and is ready for distribution. The market immediately shot its stock from $36 to $42. Next, people started commenting that having the vaccine ready is not enough – there are quite a few problems around it, such as storage, delivery, pricing, etc. And the market went “ok then, I’m getting back down” – so the stock dropped to almost exactly where it was before the spike. Will it drop further? Possible, but the upside potential is still there – technically, and fundamentally. Very probably, in a week or so, the share price will penetrate $39, just on a milted upward curve. But that’s not the most interesting thing: Moderna has just announced that its vaccine is also waiting for the release of the trial results. Let’s look at the chart.
Moderna share price was below 75$ when the announcement was made. Momentarily, the stock went all the way to $88 – a more than 10% rise just in a couple of days. So far, it is staying in that range but will it continue to $95? That may depend on what the news are on the trial results. If they are as good – or, preferably, better than – those of Pfizer, very probably it will go up to $88 and beyond. Otherwise, it will drop the same as Pfizer did, to $75. Therefore, follow the news from Moderna and act quickly if you want to benefit from those movements.
Don't know how to trade stocks? Here are some simple steps.
- First of all, be sure you’ve downloaded Metatrader 5.FBS allows you to trade stocks only through this software.
- Open the MT5 account in your personal area.
- Reveal all trading instruments by clicking “show all” at the “Market Watch” window.
- Start trading!